Search results for " Major"

showing 10 items of 361 documents

The long and complex road in the search for treatment for mental disorders: An analysis of the process in five groups of patients

2016

Seeking treatment for mental-health problems is a complex process, with different underlying motives in each stage. However, the entire process and these motives have hardly been investigated. This study aims to analyze the different stages of the help-seeking process and their underlying motives in five groups of patients with different mental disorders. In all, 156 patients seeking treatment in outpatient mental health clinics were individually interviewed: 71 had Obsessive-Compulsive Disorder (OCD), 21 had Agoraphobia (AGO), 18 had Major Depressive Disorder (MDD), 20 had Anorexia Nervosa (AN), and 22 had Cocaine Dependence (COC). The AGO and MDD patients delayed significantly less time i…

AdultMaleObsessive-Compulsive Disordermedicine.medical_specialtyAnorexia NervosaSocial stigmaSocial StigmaPoison controlSuicide preventionTime-to-TreatmentCocaine dependenceCocaine-Related Disorders03 medical and health sciencesHelp-Seeking Behavior0302 clinical medicinemental disordersInjury preventionmedicineHumansPsychiatryAgoraphobiaBiological PsychiatryDepressive Disorder Majorbusiness.industryMental DisordersMiddle Agedmedicine.diseaseMental health030227 psychiatryPsychiatry and Mental healthMajor depressive disorderFemalebusinessAttitude to Health030217 neurology & neurosurgeryAgoraphobiaClinical psychologyPsychiatry Research
researchProduct

TheMAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression

2006

This study investigated the possible association of the MAOA T941G gene variant with differential antidepressant response to mirtazapine and/or paroxetine in 102 patients with major depression (DSM-IV criteria) participating in a randomized double-blind controlled clinical trial. Female mirtazapine-treated patients homozygous for the T-allele had a significantly faster and better treatment response than TG/GG-patients. In males, we failed to show an association between MAOA T941G gene variant and mirtazapine response. In the paroxetine-treated group, there were no significant differences in treatment response between MAOA T941G genotype groups. Time course of response and antidepressant eff…

AdultMaleOncologymedicine.medical_specialtyTime FactorsGenotypeGenetic LinkageMirtazapineMirtazapineMianserinPolymorphism Single NucleotideCellular and Molecular NeuroscienceDouble-Blind MethodGene FrequencyInternal medicineGenotypemedicineHumansAlleleMonoamine OxidaseGenotypingGenetics (clinical)Depressive Disorder MajorSex Characteristicsbusiness.industryMiddle AgedParoxetineAntidepressive AgentsClinical trialParoxetinePsychiatry and Mental healthTreatment OutcomeEndocrinologyAntidepressantFemalebusinessReuptake inhibitormedicine.drugAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics
researchProduct

Analysis of 55 cases of adenomatoid odontogenic tumor in an Indian population and review of literature

2021

Background This study reviews the demographic, clinical and radiographic features of adenomatoid odontogenic tumor(AOT) diagnosed in an Indian population over 50 years and also evaluate and compare follicular AOT(F-AOT) and extra-follicular AOT(EF-AOT). Material and Methods 55 diagnosed cases of AOT from 1971-2020 were studied retrospectively. The data regarding the age, sex, location, variant of AOT, duration, clinical features, radiographic appearance, treatment and recurrence were collected and analysed. Results Of the 722 odontogenic tumors diagnosed, 7.6% were AOTs with higher prevalence of extra-follicular (67.3%) than follicular (32.7%) variant. All the tumors were intraosseous with …

AdultMaleOral Medicine and PathologyAdolescentbeta-thalassemia majorResearchTooth ImpactedIndiaOdontogenic TumorsAmeloblastomaYoung AdultOtorhinolaryngologyfractalspanoramic radiographyHumansFemaleSurgeryChildGeneral DentistryUNESCO:CIENCIAS MÉDICASRetrospective Studies
researchProduct

Effects of age on depressive symptomatology and response to antidepressant treatment in patients with major depressive disorder aged 18 to 65 years

2020

Background: There is evidence that symptomatology in patients with major depressive disorder (MDD) changes with age. However, studies comparing depressive symptomatology between different age groups during antidepressant therapy are rare. We compared demographic and clinical characteristics in depressed patients of different age groups at baseline and during treatment. Methods: 889 MDD inpatients were divided into four age groups (18–29, 30–39, 40–49, 50–65 yrs.). Demographic and clinical characteristics including depressive symptomatology (assessed by the Inventory of Depressive Symptoms) were assessed at baseline and weekly during treatment. Results: At baseline, young patients (18–29 yea…

AdultMalePediatricsmedicine.medical_specialtyAdolescentlcsh:RC435-571IrritabilityDepressive symptomatology03 medical and health sciencesYoung Adult0302 clinical medicinelcsh:PsychiatrymedicineHumansIn patientDepression (differential diagnoses)AgedDepressive Disorder Majorbusiness.industryDepressionAge FactorsMiddle Agedmedicine.diseasePersonality disordersAntidepressive AgentsIrritable MoodSelf Concept030227 psychiatrySubstance abusePsychiatry and Mental healthClinical PsychologyTreatment OutcomeAntidepressantMajor depressive disorderFemalemedicine.symptombusiness030217 neurology & neurosurgeryComprehensive Psychiatry
researchProduct

Remission in schizophrenia — What are we measuring? Comparing the consensus remission criteria to a CGI-based definition of remission and to remissio…

2019

Despite being recommended for use in clinical trials, the consensus remission criteria were found to leave patients with persisting symptoms, relevant areas of functional impairment and a decreased sense of wellbeing. Therefore, to evaluate the appropriateness of the schizophrenia consensus criteria, a definition of remission based on the Clinical Global Impression Scale (CGI) was developed and remitter subgroups were compared.239 patients with a schizophrenia spectrum disorder were evaluated regarding their remission status after inpatient treatment. Remission in schizophrenia was defined according to the symptom-severity component of the consensus criteria by Andreasen et al. and a CGI ba…

AdultMalePediatricsmedicine.medical_specialtyConsensusMedizinConsensus criteriaSeverity of Illness IndexAsymptomaticYoung Adult03 medical and health sciences0302 clinical medicineRemission criteriaOutcome Assessment Health Caremental disordersmedicineHumansBiological PsychiatryDepression (differential diagnoses)Depressive Disorder Majorbusiness.industryRemission InductionMiddle Agedmedicine.disease030227 psychiatry3. Good healthClinical trialPsychiatry and Mental healthSchizophreniaSchizophreniaClinical Global ImpressionFemalemedicine.symptombusiness030217 neurology & neurosurgeryFollow-Up StudiesSchizophrenia spectrum
researchProduct

A Confirmatory Study on the Mechanisms Behind Reduced P300 Waves in Depression

2003

A single-trial analysis of event-related potentials (P300) of 21 depressives was performed in comparison with matched controls. The purpose was to confirm previous results revealing an overall reduction of the single-trial P300 amplitude in depression despite fewer elicited single-trial P300 waves in schizophrenics. The result of the present study is in line with our previous investigation implicating a general reduced P300 amplitude on single trials of depressive patients. Therefore, it appears possible to differentiate depressives and schizophrenics by measuring event-related potentials and applying a single-trial analysis of them.

AdultMalePharmacologyAnalysis of VarianceDepressive Disorder Majormedicine.medical_specialtyCase-control studyMiddle AgedAudiologyP300 amplitudeEvent-Related Potentials P300Developmental psychologyPsychiatry and Mental healthEvent-related potentialLinear ModelsmedicineHumansFemalePsychologyDepression (differential diagnoses)Neuropsychopharmacology
researchProduct

Defining response and remission in psychotherapy research: A comparison of the RCI and the method of percent improvement

2011

There is no consensus as to how to define response and remission for mental disorder treatments. The Reliable Change Index (RCI) is most commonly used in psychotherapy research, whereas psychopharmacologists prefer to calculate percentage of improvement (PI). We compared both methods using the Beck Depression Inventory in 395 depressive outpatients. The overall pre-post effect size was d=1.18. The PI-50 (≥ 50% improvement from baseline) resulted in outcome estimates higher than the RCI: 66.3% vs. 59.2% for response and 50.6% vs. 45.8% for remission. We demonstrate that the PI approach is independent of arbitrarily chosen reliabilities and reference populations. Furthermore, it takes differe…

AdultMalePsychiatric Status Rating ScalesDepressive Disorder MajorPsychotherapistPsychometricsPsychometricsEndpoint DeterminationTreatment outcomeBeck Depression InventoryReproducibility of ResultsPsychotherapyClinical PsychologyTreatment OutcomeGermanyPsychiatric status rating scalesHumansFemaleDysthymic DisorderPsychologyPsychotherapy Research
researchProduct

Three dimensions of depression in patients with acute psychotic disorders: A replication study

1999

Depressive symptoms in psychotic disorders are of high relevance but seem to be heterogeneous when assessed with a standard rating scale. The present analysis is a replication study on the dimensionality of the Bech-Rafaelsen Melancholia Scale (BRMES) in acutely psychotic patients with substantial depression defined according to a functional approach across the nosological borders of schizophrenia with major affective symptoms, schizoaffective disorder, depressed subtype, and major depression with psychotic features. The baseline data of 123 patients participating in a multicenter pharmacological trial were evaluated with structural equation models. A previously reported three-dimensional m…

AdultMalePsychosismedicine.medical_specialtyAdolescentPsychometricslcsh:RC435-571Schizoaffective disorderSeverity of Illness IndexStructural equation modelingRating scalelcsh:PsychiatryMelancholiamedicineHumansPsychiatryAgedPsychiatric Status Rating ScalesDepressive Disorder MajorReproducibility of ResultsMiddle Agedmedicine.diseasePsychiatry and Mental healthClinical PsychologyPsychotic DisordersSchizophreniaAcute DiseaseSchizophreniaFemaleSchizophrenic PsychologyPsychomotor Disordersmedicine.symptomFactor Analysis StatisticalPsychologyPsychomotor disorderClinical psychologyComprehensive Psychiatry
researchProduct

Detection of Depression in Acute Schizophrenia: Sensitivity and Specificity of 2 Standard Observer Rating Scales

2006

Objective: To compare the psychometric properties of the Calgary Depression Rating Scale (CDRS) and the Hamilton Depression Rating Scale (HDRS) for severity assessment of depression in acute schizophrenia. Method: During clinical routine treatment, we investigated 119 inpatients with acute schizophrenia, using the CDRS, the HDRS, and a global 4-point Depression Severity Scale (DEP-SEV). We compared CDRS and HDRS sum scores regarding their diagnostic accuracy, with global severity of depression as the criterion. We estimated sensitivity and specificity on the basis of receiver operating characteristic curves. Results: According to global clinical ratings (DEP-SEV), 31% of patients had no dep…

AdultMalePsychosismedicine.medical_specialtyPsychometricsAcute schizophreniaStatistics as TopicComorbidityPersonality AssessmentSeverity assessmentRating scaleGermanymedicineHumansPsychiatryDepression (differential diagnoses)Psychiatric Status Rating ScalesDepressive Disorder MajorReproducibility of Resultsmedicine.diseasePsychiatry and Mental healthROC CurveSchizophreniaAcute DiseaseSchizophreniaFemaleStandard observerPsychologyClinical psychologyThe Canadian Journal of Psychiatry
researchProduct

The effect of improvisational music therapy on the treatment of depression: protocol for a randomised controlled trial

2008

Abstract Background Music therapy is frequently offered to individuals suffering from depression. Despite the lack of research into the effects of music therapy on this population, anecdotal evidence suggests that the results are rather promising. The aim of this study is to examine whether improvisational, psychodynamically orientated music therapy in an individual setting helps reduce symptoms of depression and improve other health-related outcomes. In particular, attention will be given to mediator agents, such as musical expression and interaction in the sessions, as well as to the explanatory potential of EEG recordings in investigating emotion related music perception of individuals w…

AdultMaleResearch designPsychotherapistMusic therapyAdolescentlcsh:RC435-571PopulationContext (language use)Severity of Illness Indexbehavioral disciplines and activitieslaw.inventionStudy ProtocolRandomized controlled triallawlcsh:PsychiatryHumanseducationMusic TherapyDepression (differential diagnoses)Depressive Disorder Majoreducation.field_of_studyMusical expressionMiddle AgedhumanitiesDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthTreatment OutcomeResearch DesignFemalePsychologyPeriod (music)Clinical psychologyBMC Psychiatry
researchProduct